Gritstone bio, Inc.
GRTS · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $57 | $49 | $29 | $1,565 |
| % Growth | 16.3% | 69% | -98.1% | – |
| Cost of Goods Sold | $1,600 | $1,742 | $1,921 | $1,964 |
| Gross Profit | -$1,543 | -$1,693 | -$1,892 | -$399 |
| % Margin | -2,707% | -3,455.1% | -6,524.1% | -25.5% |
| R&D Expenses | $20,811 | $33,041 | $32,938 | $32,763 |
| G&A Expenses | $7,698 | $8,502 | $7,916 | $7,406 |
| SG&A Expenses | $6,098 | $6,760 | $5,995 | $7,406 |
| Sales & Mktg Exp. | -$1,600 | -$1,742 | -$1,921 | $0 |
| Other Operating Expenses | $0 | $0 | -$4 | -$6 |
| Operating Expenses | $26,909 | $39,801 | $38,933 | $40,169 |
| Operating Income | -$28,452 | -$41,494 | -$40,825 | -$38,604 |
| % Margin | -49,915.8% | -84,681.6% | -140,775.9% | -2,466.7% |
| Other Income/Exp. Net | $4,192 | -$584 | -$347 | $170 |
| Pre-Tax Income | -$23,396 | -$40,385 | -$30,818 | -$38,434 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23,396 | -$40,385 | -$30,818 | -$38,434 |
| % Margin | -41,045.6% | -82,418.4% | -106,269% | -2,455.8% |
| EPS | -0.16 | -0.34 | -0.32 | -0.33 |
| % Growth | 52.9% | -6.3% | 3% | – |
| EPS Diluted | -0.16 | -0.34 | -0.32 | -0.33 |
| Weighted Avg Shares Out | 143,297 | 118,391 | 97,585 | 115,343 |
| Weighted Avg Shares Out Dil | 143,297 | 118,391 | 97,585 | 115,343 |
| Supplemental Information | – | – | – | – |
| Interest Income | $691 | $712 | $875 | $1,167 |
| Interest Expense | $1,304 | $1,296 | $1,218 | $991 |
| Depreciation & Amortization | $1,600 | $1,742 | $1,921 | $1,964 |
| EBITDA | -$20,492 | -$37,347 | -$27,679 | -$35,479 |
| % Margin | -35,950.9% | -76,218.4% | -95,444.8% | -2,267% |